Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella.

Doggen, Krisvan Hoek, Albert JanLuyten, Jeroen2023-02-282023-02-282023-02-213680967310.1007/s40273-023-01252-zhttp://hdl.handle.net/10029/626495en© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella.Article1179-2027Pharmacoeconomics 2023; 41(5):481-497